Azole Antifungal Prophylaxis of Invasive Fungal Infections in Immunocompromised Patients: Questions and Answers for Pharmacists. (PubMed, J Pharm Technol) - Jul 2, 2026 - "Posaconazole has demonstrated superiority over fluconazole and itraconazole in neutropenic leukemia populations, while mold-active azoles including voriconazole and isavuconazole offer expanded prophylactic options in select patients. Pharmacists play a central role in optimizing prophylaxis through therapeutic drug monitoring, medication reconciliation, and toxicity mitigation. Additional studies are needed to optimize prophylaxis strategies and improve patient outcomes."
Journal • Review • Bone Marrow Transplantation • Hematological Disorders • Hematological Malignancies • Infectious Disease • Leukemia • Oncology • Pediatrics • Psychiatry • Transplantation
|
|
Jacob M Kupetz; Justin P Reinert; Kevin N Standen; Loulwa Maktabi
|